462 results on '"A. Maulard"'
Search Results
2. Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
3. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis
4. Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection
5. Stratégies thérapeutiques post-chirurgicales actuelles dans les cancers de l’ovaire en première ligne de traitement
6. Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
7. Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
8. Should Secondary Cytoreductive Surgery be Offered to all Patients that are Surgical Candidates with Optimally Resectable Recurrent Uterine Leiomyosarcoma?
9. Fertility-Sparing Strategy in Ovarian Tumors
10. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors
11. Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements
12. Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.
13. Oncologic results of fertility sparing surgery of cervical cancer: An updated systematic review
14. La préservation de fertilité en cas de cancer du col, analyse de 30 ans de pratique et immersion dans les évolutions à venir
15. Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti-VEGF agents: a retrospective study
16. An evaluation of cell-free tumor DNA from 20 mL of peritoneal fluid for homologous recombination deficiency (HRD) testing in newly diagnosed ovarian cancer (OC).
17. Exploring the tumor microenvironment (TME) in patients with mismatch repair-deficient (MMRd) endometrial cancer (EC) undergoing immune checkpoint inhibitor (ICI) therapy: Proteomic insights into immune resistance mechanisms.
18. Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management
19. Désescalade chirurgicale en oncologie gynécologique
20. Carcinome séreux de bas grade ovarien à un stade avancé : étude rétrospective sur 34 patientes en résection complète
21. Brenner Borderline Ovarian Tumor: A Case Series and Literature Review
22. Distribution of novel immune-checkpoint targets in ovarian cancer tumor microenvironment: A dynamic landscape.
23. Cancer
24. Results After Conservative Surgery of Stage II/III Serous Borderline Ovarian Tumors
25. Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patients
26. A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer
27. Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors
28. Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy
29. ASO Visual Abstract: Endometrioid Borderline Ovarian Tumor–Clinical Characteristics, Prognosis, and Management
30. False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology
31. Recurrence Risk Factors And Obstetric Outcomes In Advanced-Stage Borderline Serous Ovarian Tumors
32. Evaluating The Impact Of Surgical Lymph Node Staging On Risk Stratification In Early-Stage Endometrial Cancer In The Molecular Classification Era.
33. Urinary Complications Of Bricker Procedures In Oncogynecology: A Monocentric Retrospective Analysis Of 77 Cases Over 20 Years
34. Prognosis Of Stage-I Ovarian Mucinous Tumors According To Expansile And Infiltrative Types
35. Fertility results and oncologic outcomes in patients with stage II and III serous borderline ovarian tumors
36. Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer
37. Chirurgia dei tumori epiteliali maligni dell’ovaio
38. Cirugía de los tumores epiteliales malignos ováricos
39. Estrategias quirúrgicas en tumores limítrofes de ovario
40. Cirugía de tumores epiteliales malignos del ovario
41. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
42. Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
43. Theragnostic Gadolinium-Based Nanoparticles Safely Augment X‑ray Radiation Effects in Patients with Cervical Cancer.
44. Chirurgie des cancers gynécologiques et préservation de la fertilité
45. Gynaecologic cancer surgery and preservation of fertility
46. ASO Visual Abstract: Brenner Borderline Ovarian Tumor—A Case Series and Literature Review
47. Clinical utility of SMARCA4 testing by immunohistochemistry in rare ovarian tumours
48. Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
49. Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients
50. #461 Patient reported outcomes from CCTG CX.5 (SHAPE): randomized trial comparing radical hysterectomy (RH) and pelvic node dissection (PND) vs simple hysterectomy (SH) and PND in women with low-risk early-stage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.